Monivent AB (XSAT:MONI) Total Liabilities: kr13.96 Mil (As of Mar. 2026)

What is Monivent AB Total Liabilities?

Monivent AB XSAT:MONI -3.64% 21 Total Liabilities is kr13.96 Mil as of Mar. 2026. GuruFocus rates XSAT:MONI with a GF Score™ of 21/100 and a GF Value™ of kr0.05 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Monivent AB's Total Liabilities for the quarter that ended in Mar. 2026 was kr13.96 Mil.

Monivent AB's quarterly Total Liabilities increased from Sep. 2025 (kr9.86 Mil) to Dec. 2025 (kr10.13 Mil) and increased from Dec. 2025 (kr10.13 Mil) to Mar. 2026 (kr13.96 Mil).

Monivent AB's annual Total Liabilities increased from Dec. 2023 (kr7.31 Mil) to Dec. 2024 (kr10.70 Mil) but then declined from Dec. 2024 (kr10.70 Mil) to Dec. 2025 (kr10.13 Mil).

Monivent AB Total Liabilities Related Terms

Monivent AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Monivent AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monivent AB Total Liabilities Chart

Monivent AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

2.67

2.76

7.31

10.70

10.13

Monivent AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															6.03	7.04	9.86	10.13	13.96

21GF Score

Monivent AB XSAT:MONI

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Monivent AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Monivent AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.003	+	(0.353	+	2.77
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	10.13

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	12.78	-	2.654
	=	10.13

Monivent AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11.163	+	(0	+	2.797
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	13.96

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	14.001	-	0.041
	=	13.96

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of kr13.96 Mil mean?

Monivent AB (XSAT:MONI) has a Total Liabilities of kr13.96 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Monivent AB and its competitors.

Is Monivent AB's Total Liabilities too high?

Monivent AB's current Total Liabilities is kr13.96 Mil. Overall, Monivent AB has a GF Score™ of 21/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Monivent AB's Total Liabilities compare to ABT and SYK?

Monivent AB's Total Liabilities of kr13.96 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Devices & Instruments company?

A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Monivent AB and its competitors. Monivent AB's current Total Liabilities is kr13.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Monivent AB stock overvalued right now?

Based on GuruFocus' analysis, Monivent AB (XSAT:MONI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.16 — trading 218% above its estimated fair value. The current Total Liabilities is kr13.96 Mil. Monivent AB's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Monivent AB (XSAT:MONI), the current Total Liabilities is kr13.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monivent AB (XSAT:MONI) Overvalued in 2026?

Based on GuruFocus' analysis, Monivent AB stock appears to be overvalued. The current stock price of kr0.16 is trading 218% above its estimated GF Value™ of kr0.05. GuruFocus considers Monivent AB to be Significantly Overvalued.

Key valuation signals for XSAT:MONI:

Total Liabilities: kr13.96 Mil
GF Value™: kr0.05 vs. price of kr0.16 (218% above fair value)
GF Score™: 21/100 with 5 warning signs

No single metric tells the full story. See the XSAT:MONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monivent AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XSAT:POLAR OSTO:PERP B XSAT:VSD B XSAT:ZENI OSTO:SPEC OSTO:SDOS XSAT:IMS OSTO:LXB XSAT:ISAB OSTO:QLIFE ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55

Website https://www.monivent.se

Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.

21GF Score

Get the complete analysis for XSAT:MONI

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.16

Price

kr0.05

GF Value

View XSAT:MONI Analysis

See Total Liabilities data for all stocks →